CSAC Bulletin Article

Food and Drug Administration Releases New Guidance on Monkeypox (MPX)

September 8, 2022

The Food and Drug Administration (FDA) released new guidance on MPX to help increase availability of tests and expand available testing capabilities in healthcare settings, reference laboratories, and commercial laboratories. The guidance follows a declaration by the Secretary of the Department of Health and Human Services justifying the emergency use authorization (EUA) of in vitro diagnostics for detection and/or diagnosis of the MPX virus or non-variola orthopoxviruses.

CSAC will continue to work with local public health officials to seek adequate resources to support prevention and mitigation efforts. Those wanting to learn more about MPX transmission, symptoms, and prevention, as well as data on the number of reported cases, including demographic detail, can visit the California Department of Public Health’s webpage.

Navigation Term Highlight

Latest CSAC Bulletin

CSAC Bulletin Button
Navigation Term Highlight

Where We are Located

Navigation Term Highlight

Our 58 Counties